Tuesday, August 20, 2013 5:07:41 PM
Recent SUPN News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2024 10:00:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2024 09:33:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 09:13:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 09:08:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2024 09:59:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2024 09:55:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:19:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:13:12 PM
- Supernus Announces Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/04/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/01/2024 08:35:56 PM
- Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024 • GlobeNewswire Inc. • 10/31/2024 08:10:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:38:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 08:48:11 PM
- Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/21/2024 08:25:48 PM
- iPhone 16 Sales in China Up 20%; Sobr Safe Jumps 108% Pre-Market; Netflix and Intuitive Surgical Beat Estimates • IH Market News • 10/18/2024 10:09:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:16:40 PM
- Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder • GlobeNewswire Inc. • 10/17/2024 08:05:25 PM
- Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder • GlobeNewswire Inc. • 10/10/2024 09:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 09:03:28 PM
- Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree • GlobeNewswire Inc. • 09/24/2024 11:30:33 AM
- Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit • GlobeNewswire Inc. • 09/19/2024 08:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 09:00:12 PM
- Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:00:14 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM